Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125986221 | 12598622 | 1 | I | 20160322 | 20160726 | 20160726 | EXP | AT-MYLANLABS-2016M1012621 | MYLAN | DR. ALEXANDER MENG. SIE FRAGEN R EXPERTEN ANTWORTEN. ARZTE KRONE. 2016;5 (16):24 | 0.00 | Y | 0.00000 | 20160726 | MD | AT | AT |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125986221 | 12598622 | 1 | PS | GABAPENTIN. | GABAPENTIN | 1 | UNK | U | U | 90335 | |||||||||
| 125986221 | 12598622 | 2 | SS | GLADEM | SERTRALINE HYDROCHLORIDE | 1 | UNK | U | 0 | ||||||||||
| 125986221 | 12598622 | 3 | C | TRAMABENE | 2 | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125986221 | 12598622 | 1 | Neuralgia |
| 125986221 | 12598622 | 2 | Product used for unknown indication |
| 125986221 | 12598622 | 3 | Product used for unknown indication |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125986221 | 12598622 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125986221 | 12598622 | Arrhythmia | |
| 125986221 | 12598622 | Hypertonia | |
| 125986221 | 12598622 | Insomnia | |
| 125986221 | 12598622 | Nausea |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |